Blankenship et al v. Bayer Corporation et al

Filing 26

ORDER REMANDING ACTION by Hon. William Alsup granting 25 Stipulation.(whalc1, COURT STAFF) (Filed on 6/20/2017)

Download PDF
1 4 Laura J. Baughman, CA SBN 263944 Baron & Budd, P.C. 3102 Oak Lawn Avenue, Suite 1100 Dallas, Texas 75219 Telephone: (214) 521-3605 Facsimile: (214) 520-1181 Email: lbaughman@baronbudd.com 5 Attorney for Plaintiffs 6 Alycia A. Degen, SBN 211350 adegen@sidley.com Bradley J. Dugan, SBN 271870 bdugan@sidley.com SIDLEY AUSTIN LLP 555 West Fifth Street, Suite 4000 Los Angeles, California 90013 Telephone: 1-213-896-6000 Facsimile: 1-213-896-6600 2 3 7 8 9 10 11 12 Attorneys for Defendants and Specially Appearing Defendants Bayer Corporation, Bayer Essure Inc., Bayer HealthCare LLC, Bayer HealthCare Pharmaceuticals Inc. 13 14 15 UNITED STATES DISTRICT COURT 16 NORTHERN DISTRICT OF CALIFORNIA 17 18 19 LEANNA BLANKENSHIP, et al.; 20 21 22 23 24 25 26 27 Plaintiffs, v. CASE NO. 3:17-cv-02230-WHA JOINT STIPULATION TO REMAND; [PROPOSED] ORDER BAYER CORP., an Indiana corporation; BAYER HEALTHCARE LLC, a Delaware company; BAYER ESSURE INC. (F/K/A CONCEPTUS, INC.), a Delaware corporation; BAYER HEALTHCARE PHARMACEUTICALS, INC., a Delaware corporation; and DOES 1-10, inclusive, Defendants. 28 JOINT STIPULATION TO REMAND; CASE NO. 3:17-cv-02230-WHA 1 Plaintiffs Leanna Blankenship, et al., and defendants and specially-appearing defendants 2 Bayer Corporation, Bayer Essure Inc., Bayer HealthCare LLC, and Bayer HealthCare 3 Pharmaceuticals Inc. (collectively, “Bayer”), hereby stipulate and agree as follows: 4 1. Plaintiffs filed their initial Complaint on March 10, 2017, and their First Amended 5 Complaint on March 21, 2017, in the Superior Court for the State of California, County of 6 Riverside. In their Complaint and First Amended Complaint, Plaintiffs asserted claims involving 7 the Essure® Permanent Birth Control System (the “Essure® Device”). 8 9 10 11 12 13 2. On April 3, 2017, the Coordination Trial Judge of the Superior Court of the State of California, County of Alameda, granted Plaintiffs’ petition for coordination of add-on case with the Judicial Council Coordinated Proceeding (“JCCP”) 4887. 3. On April 21, 2017, Bayer removed the matter from the Alameda County Superior Court to the United States District Court for the Northern District of California. 4. On April 21, 2017, Bayer filed an administrative motion to relate this matter to 14 another matter pending in the Northern District of California involving the Essure® Device, 15 captioned as Elizabeth Ann Sangimino, et al. v. Bayer Corp., et al., Case No. 3:17-cv-01488-WHA. 16 17 18 5. Bayer filed its Motion to Dismiss on April 28, 2017, on the grounds of federal preemption, among other grounds. 6. On May 3, 2017 the parties filed a stipulation to stay briefing on Plaintiffs’ 19 anticipated Motion to Remand, and on Defendants’ Motion to Dismiss pending the Northern 20 District of California’s rulings on the Motion to Dismiss and Motion to Remand in Sangimino. The 21 Court granted the parties’ Stipulation on May 4, 2017. 22 7. On May 19, 2017, Plaintiffs moved to remand this action to the Superior Court of 23 Alameda County, State of California, pursuant to 28 U.S.C. § 1447, on the grounds that this Court 24 lacks jurisdiction over this action. 25 26 8. On June 9, 2017, this Court granted Plaintiffs’ Motion to Remand in the Sangimino matter and denied the Motion to Dismiss as moot. 27 28 1 JOINT STIPULATION TO REMAND; CASE NO. 3:17-cv-02230-WHA 1 2 3 4 5 6 9. The parties have met and conferred and agree to remand this case to the Alameda County Superior Court. 10. The parties thus respectfully ask the Court to enter an order remanding this case to state court based on the stipulation of the parties. IT IS SO STIPULATED. Dated: June 19, 2017 7 By: /s/Laura J. Baughman Laura J. Baughman Sindhu S. Daniel Russell W. Budd 8 9 Attorneys for Plaintiffs 10 11 12 13 14 15 16 BARON & BUDD, P.C. Dated: June 19, 2017 SIDLEY AUSTIN LLP By: /s/Alycia A. Degen Alycia A. Degen Bradley J. Dugan Attorneys for Defendants and Specially Appearing Defendants Bayer Corporation, Bayer HealthCare LLC, Bayer Essure Inc., and Bayer HealthCare Pharmaceuticals Inc. 17 18 19 20 21 22 23 24 25 26 27 28 2 JOINT STIPULATION TO REMAND; CASE NO. 3:17-cv-02230-WHA 1 2 3 4 5 6 UNITED STATES DISTRICT COURT 7 NORTHERN DISTRICT OF CALIFORNIA 8 9 LEANNA BLANKENSHIP, et al; 10 11 12 13 14 15 16 17 CASE NO. 3:17-cv-02230-WHA Plaintiffs, [PROPOSED] ORDER RE JOINT STIPULATION TO REMAND v. BAYER CORP., an Indiana corporation; BAYER HEALTHCARE LLC, a Delaware company; BAYER ESSURE INC. (F/K/A CONCEPTUS, INC.), a Delaware corporation; BAYER HEALTHCARE PHARMACEUTICALS, INC., a Delaware corporation; and DOES 1-10, inclusive, Defendants. 18 19 20 PURSUANT TO THE PARTIES’ STIPULATION, and for good cause shown, IT IS 21 ORDERED THAT Blankenship v. Bayer Corporation, Case No. 3:17-cv-02230-WHA, be 22 remanded to the Superior Court of the State of California, County of Alameda. 23 June 20, 2017. DATED: __________________ ___________________________________ Honorable William Alsup 24 25 26 27 28 1 [PROPOSED] ORDER RE JOINT STIPULATION TO REMAND - CASE NO. 3:17-cv-02230-WHA

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?